SGI
HRMY icon

Summit Global Investments’s Harmony Biosciences HRMY Stock Holding History

Summit Global Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$984K Hold
27,034
– – 0.05% 208
2026
Q1 		$757K Buy
27,034
+3,841
+17% +$126K 0.04% 251
2025
Q4 		$868K Sell
23,193
-6,952
-23% -$229K 0.05% 224
2025
Q3 		$831K Buy
30,145
+9,404
+45% +$324K 0.05% 226
2025
Q2 		$655K Sell
20,741
-8,441
-29% -$272K 0.04% 264
2025
Q1 		$969K Sell
29,182
-1,108
-4% -$39.7K 0.07% 173
2024
Q4 		$1.04M Buy
30,290
+11,027
+57% +$379K 0.07% 205
2024
Q3 		$771K Sell
19,263
-901
-4% -$31.6K 0.05% 280
2024
Q2 		$608K Buy
20,164
+807
+4% +$24.3K 0.04% 314
2024
Q1 		$650K Buy
19,357
+3,184
+20% +$102K 0.05% 286
2023
Q4 		$522K Buy
+16,173
New +$451K 0.03% 332
2023
Q3 		– Sell
-9,827
Closed -$346K – 559
2023
Q2 		$346K Buy
+9,827
New +$339K 0.02% 399

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Summit Global Investments's HRMY Position: Q2 2026 in Review

Summit Global Investments held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 27,034 shares worth $984K. The position accounts for 0.05% of the portfolio, ranked #208.

Summit Global Investments first reported a position in HRMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.04M in Q4 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Summit Global Investments held 27,034 shares of Harmony Biosciences worth $984K as of Q2 2026.
  • Summit Global Investments left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.05% of Summit Global Investments's portfolio in Q2 2026, its #208 holding.
  • Summit Global Investments first reported a position in Harmony Biosciences in Q2 2023 and has held it in 12 quarters since.
  • Summit Global Investments's Harmony Biosciences position peaked at $1.04M in Q4 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.